4th Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislative issues that would allow incentives for the discovery and FDA approval of new antibiotics. Regulatory issues surrounding Unique Device Identifiers (UDI) being addressed by the Food and Drug Administration and Congressional oversight Regulatory issues regarding Meaningful Use 3 regulations being considered by CMS and congressional oversight.Implementation and rulemaking related to the Physician Payment Sunshine Act - A Medicare-related provision in the Health Reform Law focused on increasing systemic transparency. H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries. H.R.3204 - Drug Quality and Security Act - Legislation that addresses security of the nation's pharmaceutical supply chain and drug compounding practices.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th), H.R. 933 (113th)

Medicare/Medicaid MMM

Implementation and rulemaking related to the Physician Payment Sunshine Act- a Medicare-related provision in the health reform law focused on systemic transparency. Discussions of including the new unique device identifiers in materials related to Medicare.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3204 - The Drug Quality and Security Act - Legislation to address the security of the nation's pharmaceutical supply chain anddrug compounding practices. H.R. 933 - Consolidation and Further Continuing Appropriations Act of 2013 - Focused on funding for the FDA, CDC and other public health related industries.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 933 (113th), H.R. 3204 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.